Continuous infusion 5-fluorouracil (5FU) as a novel treatment for heavily pretreated prostate cancer patients: An update.

被引：4
|
作者：
Manogue, Charlotte
Cotogno, Patrick
Moses, Marcus Marie
Barata, Pedro C.
Layton, Jodi Lyn
Sartor, A. Oliver
Lewis, Brian E.
机构：
[1] Tulane Univ, Ctr Canc, New Orleans, LA 70118 USA
[2] Tulane Canc Ctr, Off Clin Res, New Orleans, LA USA
[3] Tulane Univ, New Orleans, LA 70118 USA
[4] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[5] Tulane Med Sch, New Orleans, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.319
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
319
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A role for levamisole (LEV) in the adjuvant treatment of stage III colon cancer: A randomized trial of 5-fluorouracil (5FU) and LEV vs 5FU alone
    Catalano, V
    Cascinu, S
    Latini, L
    Mattioli, R
    Marcellini, M
    Pancotti, A
    Bascioni, R
    Torresi, U
    Silva, RR
    Pieroni, V
    Giorgi, F
    Testa, I
    Sturba, F
    Ferretti, B
    Catalano, G
    Cellerino, R
    ANNALS OF ONCOLOGY, 2000, 11 : 66 - 66
  • [32] The impact of sarcopenia on toxicity and pharmacokinetics of 5-fluorouracil (5FU) in colorectal cancer.
    Williams, Grant Richard
    Deal, Allison Mary
    Shachar, Shlomit S.
    Walko, Christine Marie
    Patel, Jai Narendra
    O'Neil, Bert H.
    McLeod, Howard L.
    Weinberg, Marc
    Choi, Seul Ki
    Muss, Hyman B.
    Sanoff, Hanna Kelly
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [33] Continuous infusion of 5-fluorouracil (ciFU) given with vinorelbine (Vi) and cisplatin (P) (ViFUP) in heavily pretreated metastatic breast cancer
    Nolè, F
    Munzone, E
    Zampino, MG
    Minchella, I
    Colleoni, M
    Noberasco, C
    De Pas, T
    Fazio, N
    de Braud, F
    Peruzzotti, G
    Goldhirsch, A
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S7 - S7
  • [34] Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma
    Martoni, A
    Mini, E
    Pinto, C
    Nobili, S
    Gentile, AL
    Dentico, P
    Angelelli, B
    Scicolone, S
    Piana, E
    Mazzei, T
    ANNALS OF ONCOLOGY, 2001, 12 (04) : 519 - 524
  • [35] SENSITIVE HPLC ASSAY FOR 5-FLUOROURACIL (5FU) - COMPARISON WITH GLC
    CHRISTOPHIDIS, N
    MIHALY, G
    VAJDA, F
    LOUIS, W
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1979, 6 (06) : 679 - 680
  • [36] TOTAL-BODY CLEARANCE OF INFUSIONAL 5-FLUOROURACIL (5FU)
    FLOYD, R
    GRIFFITHS, J
    HORNBECK, C
    FRANKEL, S
    SHARP, T
    BYFIELD, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 395 - 395
  • [37] Proteomics analysis of the effect of fluorouracil (5FU) and 5FU/leucovorin (LV) on colorectal cancer (CRC) in patients
    Smid, Kees
    Meijer, Erik
    Pham, Thang V.
    de Reus, Inge
    Piersma, Sander R.
    Peters, Godefridus J.
    Jimenez, Connie R.
    CANCER RESEARCH, 2015, 75
  • [38] Oxaliplatin (L-OHP) in combination with leucovorin and bolus-continuous infusion 5fluorouracil (LV5FU2) in advanced colorectal cancer (ACC) pretreated with 5FU
    Beretta, GD
    Cascinu, S
    Zaniboni, A
    Ratti, R
    Giordani, P
    Catalano, V
    Martignoni, G
    Barni, S
    Frontini, L
    Labianca, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S80 - S80
  • [39] CPT11 with high-dose leucovorin (LV) and 5-Fluorouracil (5FU) 48-hour infusion in pretreated metastatic colorectal cancer (FOLFIRI)
    Andre, T
    de Gramont, A
    Louvet, C
    Carola, E
    Maindrault-Goebel, F
    Couteau, C
    Krulik, M
    Izrael, V
    ANNALS OF ONCOLOGY, 1998, 9 : 42 - 42
  • [40] Oxaliplatin with high-dose leucovorin (LV) and 5-Fluorouracil (5FU) 48-hour infusion in pretreated metastatic colorectal cancer (FOLFOX6)
    Maindrault-Goebel, F
    de Gramont, A
    Louvet, C
    Andre, T
    Carola, E
    Gilles-Amar, V
    Izrael, V
    Krulik, M
    ANNALS OF ONCOLOGY, 1998, 9 : 36 - 36
12345